272 related articles for article (PubMed ID: 28196178)
1. Association of Human Papillomavirus Vaccine With the Development of Keratinocyte Carcinomas.
Nichols AJ; Allen AH; Shareef S; Badiavas EV; Kirsner RS; Ioannides T
JAMA Dermatol; 2017 Jun; 153(6):571-574. PubMed ID: 28196178
[TBL] [Abstract][Full Text] [Related]
2. Keratinocyte Carcinomas in Immunocompromised Patients Are Reduced After Administration of the Nonavalent Human Papillomavirus Vaccine.
Nichols A; Nahm W; Rabinovitz H; Ioannides T
J Drugs Dermatol; 2022 May; 21(5):526-528. PubMed ID: 35533038
[TBL] [Abstract][Full Text] [Related]
3. Combined Systemic and Intratumoral Administration of Human Papillomavirus Vaccine to Treat Multiple Cutaneous Basaloid Squamous Cell Carcinomas.
Nichols AJ; Gonzalez A; Clark ES; Khan WN; Rosen AC; Guzman W; Rabinovitz H; Badiavas EV; Kirsner RS; Ioannides T
JAMA Dermatol; 2018 Aug; 154(8):927-930. PubMed ID: 29971321
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous squamous cell carcinoma in human immunodeficiency virus-infected patients. A study of epidemiologic risk factors, human papillomavirus, and p53 expression.
Maurer TA; Christian KV; Kerschmann RL; Berzin B; Palefsky JM; Payne D; Tyring SK; Berger TG
Arch Dermatol; 1997 May; 133(5):577-83. PubMed ID: 9158410
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus infections in nonmelanoma skin cancers from renal transplant recipients and nonimmunosuppressed patients.
Shamanin V; zur Hausen H; Lavergne D; Proby CM; Leigh IM; Neumann C; Hamm H; Goos M; Haustein UF; Jung EG; Plewig G; Wolff H; de Villiers EM
J Natl Cancer Inst; 1996 Jun; 88(12):802-11. PubMed ID: 8637046
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus infection and incidence of squamous cell and basal cell carcinomas of the skin.
Karagas MR; Nelson HH; Sehr P; Waterboer T; Stukel TA; Andrew A; Green AC; Bavinck JN; Perry A; Spencer S; Rees JR; Mott LA; Pawlita M
J Natl Cancer Inst; 2006 Mar; 98(6):389-95. PubMed ID: 16537831
[TBL] [Abstract][Full Text] [Related]
7. Association of varying number of doses of quadrivalent human papillomavirus vaccine with incidence of condyloma.
Herweijer E; Leval A; Ploner A; Eloranta S; Simard JF; Dillner J; Netterlid E; Sparén P; Arnheim-Dahlström L
JAMA; 2014 Feb; 311(6):597-603. PubMed ID: 24519299
[TBL] [Abstract][Full Text] [Related]
8. P16INK4a Immunostaining but Lack of Human Papilloma Virus Type 16 in Cutaneous Squamous Cell Carcinoma and Basal Cell Carcinoma: a Report from West Iran.
Ramezani M; Abdali E; Khazaei S; Vaisi-Raygani A; Sadeghi M
Asian Pac J Cancer Prev; 2016; 17(3):1093-6. PubMed ID: 27039730
[TBL] [Abstract][Full Text] [Related]
9. Timing of subsequent new tumors in patients who present with basal cell carcinoma or cutaneous squamous cell carcinoma.
Wehner MR; Linos E; Parvataneni R; Stuart SE; Boscardin WJ; Chren MM
JAMA Dermatol; 2015 Apr; 151(4):382-8. PubMed ID: 25588079
[TBL] [Abstract][Full Text] [Related]
10. Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial.
Muñoz N; Manalastas R; Pitisuttithum P; Tresukosol D; Monsonego J; Ault K; Clavel C; Luna J; Myers E; Hood S; Bautista O; Bryan J; Taddeo FJ; Esser MT; Vuocolo S; Haupt RM; Barr E; Saah A
Lancet; 2009 Jun; 373(9679):1949-57. PubMed ID: 19493565
[TBL] [Abstract][Full Text] [Related]
11. Different expression patterns of calpain isozymes 1 and 2 (CAPN1 and 2) in squamous cell carcinomas (SCC) and basal cell carcinomas (BCC) of human skin.
Reichrath J; Welter C; Mitschele T; Classen U; Meineke V; Tilgen W; Seifert M
J Pathol; 2003 Apr; 199(4):509-16. PubMed ID: 12635142
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity and reactogenicity of alternative schedules of HPV vaccine in Vietnam: a cluster randomized noninferiority trial.
Neuzil KM; Canh DG; Thiem VD; Janmohamed A; Huong VM; Tang Y; Diep NT; Tsu V; LaMontagne DS
JAMA; 2011 Apr; 305(14):1424-31. PubMed ID: 21486975
[TBL] [Abstract][Full Text] [Related]
13. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
Markowitz LE; Dunne EF; Saraiya M; Lawson HW; Chesson H; Unger ER; ;
MMWR Recomm Rep; 2007 Mar; 56(RR-2):1-24. PubMed ID: 17380109
[TBL] [Abstract][Full Text] [Related]
14. Basal cell carcinoma and squamous cell carcinoma growth rates and determinants of size in community patients.
Kricker A; Armstrong B; Hansen V; Watson A; Singh-Khaira G; Lecathelinais C; Goumas C; Girgis A
J Am Acad Dermatol; 2014 Mar; 70(3):456-64. PubMed ID: 24373780
[TBL] [Abstract][Full Text] [Related]
15. Detection of human papillomavirus DNA in squamous cell carcinomas of a patient with mycosis fungoides: report of a case.
Liranzo MO; Golitz L; Shroyer KR
J Cutan Pathol; 1997 Jan; 24(1):47-50. PubMed ID: 9027633
[TBL] [Abstract][Full Text] [Related]
16. Predictors of squamous cell carcinoma in high-risk patients in the VATTC trial.
Xiong MY; Rizzo AE; Cohen TS; Dyer RK; Korgavkar K; Bingham SF; Weinstock MA;
J Invest Dermatol; 2013 Jun; 133(6):1521-32. PubMed ID: 23348836
[TBL] [Abstract][Full Text] [Related]
17. Seropositivity for human papillomavirus and incidence of subsequent squamous cell and basal cell carcinomas of the skin in patients with a previous nonmelanoma skin cancer.
Paradisi A; Waterboer T; Sampogna F; Tabolli S; Simoni S; Pawlita M; Abeni D
Br J Dermatol; 2011 Oct; 165(4):782-91. PubMed ID: 21561438
[TBL] [Abstract][Full Text] [Related]
18. From the monovalent to the nine-valent HPV vaccine.
Pils S; Joura EA
Clin Microbiol Infect; 2015 Sep; 21(9):827-33. PubMed ID: 25980355
[TBL] [Abstract][Full Text] [Related]
19. Chemoprevention of nonmelanoma skin cancer with celecoxib: a randomized, double-blind, placebo-controlled trial.
Elmets CA; Viner JL; Pentland AP; Cantrell W; Lin HY; Bailey H; Kang S; Linden KG; Heffernan M; Duvic M; Richmond E; Elewski BE; Umar A; Bell W; Gordon GB
J Natl Cancer Inst; 2010 Dec; 102(24):1835-44. PubMed ID: 21115882
[TBL] [Abstract][Full Text] [Related]
20. Association of ACE inhibitors and angiotensin receptor blockers with keratinocyte cancer prevention in the randomized VATTC trial.
Christian JB; Lapane KL; Hume AL; Eaton CB; Weinstock MA;
J Natl Cancer Inst; 2008 Sep; 100(17):1223-32. PubMed ID: 18728281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
